Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7862]

WCLC 2022: Phase II study of durvalumab plus concurrent radiotherapy in unresectable locally advanced NSCLC: DOLPHIN Study

WCLC 2022: Phase II study of durvalumab plus concurrent radiotherapy in unresectable locally advanced NSCLC:...

WCLC 2022: Study of lung cancer gene panel testing demonstrates cytological specimens accurate

WCLC 2022: Study of lung cancer gene panel testing demonstrates cytological specimens accurate

WCLC 2022: Tumour bulk-RNA sequence identifies NSCLC patients at high risk of progression in non-complete pathological responders from NADIM trial

WCLC 2022: Tumour bulk-RNA sequence identifies NSCLC patients at high risk of progression in non-complete...

WCLC 2022: Sotorasib as a lead-in therapy with pembrolizumab or atezolizumab demonstrates durable clinical activity for advanced KRAS p.G12C NSCLC

WCLC 2022: Sotorasib as a lead-in therapy with pembrolizumab or atezolizumab demonstrates durable clinical...

Reinvigorating ‘lost cause’ exhausted T cells could improve cancer immunotherapy

Reinvigorating ‘lost cause’ exhausted T cells could improve cancer immunotherapy

Making better, ready-made CAR T cells for cancer immunotherapy

Making better, ready-made CAR T cells for cancer immunotherapy

New patent-pending method mass-produces antitumour cells to treat blood diseases and cancer

New patent-pending method mass-produces antitumour cells to treat blood diseases and cancer

Novel T cell bispecific antibody shows potent anti-tumour activity in preclinical models of EGFRvIII mutant glioblastoma

Novel T cell bispecific antibody shows potent anti-tumour activity in preclinical models of EGFRvIII mutant...

Leukaemia vulnerability discovered causing drug sensitivity

Leukaemia vulnerability discovered causing drug sensitivity

New link found that connects cell signalling pathway to development of oesophageal cancers, Barrett’s syndrome

New link found that connects cell signalling pathway to development of oesophageal cancers, Barrett’s syndrome

More from ecancer